{"address1": "225 Franklin Street", "address2": "Suite 2100", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "857 284 8891", "website": "https://ateapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 56, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jean-Pierre  Sommadossi Ph.D.", "age": 68, "title": "Founder, Chairman, CEO & President", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1041575, "exercisedValue": 0, "unexercisedValue": 1692200}, {"maxAge": 1, "name": "Ms. Andrea J. Corcoran J.D.", "age": 62, "title": "CFO, Executive VP of Legal & Secretary", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 712484, "exercisedValue": 0, "unexercisedValue": 369000}, {"maxAge": 1, "name": "Mr. Wayne  Foster CPA", "age": 55, "title": "Executive VP of Finance & Chief Accounting Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 580463, "exercisedValue": 0, "unexercisedValue": 281690}, {"maxAge": 1, "name": "Dr. Janet M. J.  Hammond M.D., Ph.D.", "age": 63, "title": "Chief Development Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 789473, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria Arantxa Horga M.D.", "age": 55, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 679584, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jonae R. Barnes", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adel  Moussa Ph.D.", "title": "Executive Vice President of Chemistry", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Xiao-Jian  Zhou Ph.D.", "title": "Executive Vice President of Early Stage Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John F. Vavricka", "age": 60, "title": "Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 581108, "exercisedValue": 0, "unexercisedValue": 744450}, {"maxAge": 1, "name": "Mr. Keith  Pietropaolo", "title": "Executive VP of Clinical Sciences & Project Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.99, "open": 2.96, "dayLow": 2.81, "dayHigh": 2.975, "regularMarketPreviousClose": 2.99, "regularMarketOpen": 2.96, "regularMarketDayLow": 2.81, "regularMarketDayHigh": 2.975, "payoutRatio": 0.0, "beta": 0.183, "forwardPE": -1.862745, "volume": 347976, "regularMarketVolume": 347976, "averageVolume": 340723, "averageVolume10days": 266950, "averageDailyVolume10Day": 266950, "bid": 2.83, "ask": 2.87, "bidSize": 2, "askSize": 2, "marketCap": 243746816, "fiftyTwoWeekLow": 2.75, "fiftyTwoWeekHigh": 4.145, "fiftyDayAverage": 3.069, "twoHundredDayAverage": 3.365175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -209332240, "profitMargins": 0.0, "floatShares": 66621549, "sharesOutstanding": 85525200, "sharesShort": 2914995, "sharesShortPriorMonth": 2948699, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0341, "heldPercentInsiders": 0.116610005, "heldPercentInstitutions": 0.71920997, "shortRatio": 10.02, "shortPercentOfFloat": 0.0476, "impliedSharesOutstanding": 85525200, "bookValue": 5.196, "priceToBook": 0.5484988, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -168384992, "trailingEps": -2.0, "forwardEps": -1.53, "enterpriseToEbitda": 1.588, "52WeekChange": -0.26923078, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.85, "targetHighPrice": 8.0, "targetLowPrice": 6.2, "targetMeanPrice": 7.06667, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 454720992, "totalCashPerShare": 5.317, "ebitda": -131800000, "totalDebt": 1642000, "quickRatio": 24.443, "currentRatio": 24.854, "debtToEquity": 0.374, "returnOnAssets": -0.15597, "returnOnEquity": -0.33878, "grossProfits": -83367000, "freeCashflow": -39550000, "operatingCashflow": -135499008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AVIR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -2.0, "epsForward": -1.53, "epsCurrentYear": -1.68911, "priceEpsCurrentYear": -1.687279, "fiftyDayAverageChange": -0.2190001, "fiftyDayAverageChangePercent": -0.071358785, "twoHundredDayAverageChange": -0.5151751, "twoHundredDayAverageChangePercent": -0.15309013, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-30", "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": -4.6822777, "regularMarketPrice": 2.85, "shortName": "Atea Pharmaceuticals, Inc.", "longName": "Atea Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1604064600000, "regularMarketChange": -0.1400001, "regularMarketDayRange": "2.81 - 2.975", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 340723, "fiftyTwoWeekLowChange": 0.099999905, "fiftyTwoWeekLowChangePercent": 0.0363636, "fiftyTwoWeekRange": "2.75 - 4.145", "fiftyTwoWeekHighChange": -1.2950001, "fiftyTwoWeekHighChangePercent": -0.31242463, "fiftyTwoWeekChangePercent": -26.923079, "earningsTimestamp": 1741295100, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "earningsCallTimestampStart": 1741296600, "earningsCallTimestampEnd": 1741296600, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NMS", "messageBoardId": "finmb_252824153", "displayName": "Atea Pharmaceuticals", "trailingPegRatio": null}